Sumitomo Mitsui DS Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.83M | Buy |
|
|||||
|
2025
Q1 | $3.5M | Buy |
|
|||||
|
2024
Q4 | $2.73M | Buy |
|
|||||
|
2024
Q3 | $3.19M | Sell |
|
|||||
|
2024
Q2 | $2.94M | Buy |
|
|||||
|
2024
Q1 | $1.42M | Sell |
|
|||||
|
2023
Q4 | $1.82M | Hold |
|
|||||
|
2023
Q3 | $1.69M | Sell |
|
|||||
|
2023
Q2 | $1.81M | Buy |
|
|||||
|
2023
Q1 | $1.66M | Hold |
|
|||||
|
2022
Q4 | $1.97M | Hold |
|
|||||
|
2022
Q3 | $1.66M | Buy |
|
|||||
|
2022
Q2 | $1.04M | Hold |
|
|||||
|
2022
Q1 | $1.16M | Sell |
|
|||||
|
2021
Q4 | $1.21M | Buy |
|
|||||
|
2021
Q3 | $1.12M | Sell |
|
|||||
|
2021
Q2 | $1.02M | Sell |
|
|||||
|
2021
Q1 | $855K | Buy |
|
|||||
|
2020
Q4 | $786K | Hold |
|
|||||
|
2020
Q3 | $881K | Hold |
|
|||||
|
2020
Q2 | $896K | Buy |
|
|||||
|
2020
Q1 | $658K | Buy |
|
|||||
|
2019
Q4 | $692K | Hold |
|
|||||
|
2019
Q3 | $483K | Buy |
|
|||||
|
2019
Q2 | $305K | Sell |
|
|||||
|
2019
Q1 | $1.87M | Sell |
|
|||||
|
2018
Q4 | $1.57M | Buy |
|
|||||
|
2018
Q3 | $1.7M | Sell |
|
|||||
|
2018
Q2 | $1.91M | Buy |
|
|||||
|
2018
Q1 | $661K | Sell |
|
|||||
|
2017
Q4 | $713K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $358K | Hold |
|
|||||
|
2016
Q2 | $293K | Buy |
|
|||||
|
2016
Q1 | $321K | Buy |
|
|||||
|
2015
Q4 | $477K | Hold |
|
|||||
|
2015
Q3 | $407K | Sell |
|
|||||
|
2015
Q2 | $644K | Buy |
|